Good MorningEquity markets moved on Thursday, but it may be another top in a frothy market. The latest rally is driven by hopes the banking crisis is already behind us despite the fact the FOMC is on track to hike rates 1 more time this year. The risk for traders is that PCE data release will be hot or hotter than expected and keep the Fed hiking until later in the year.
If the market can not move higher today, it will confirm resistance for the 3rd time this year. Such a move would keep the S&P 500 rage bound until the 2nd half, when there is an expectation for earnings growth. Until then, investors should stick to their investment plans and use market dips to load up on their favorite stocks. Featured: Don't Miss Out On These EPIC Profit Stocks (Darwin) 
|
Markets | | Credit Suisse shares plunged Monday after Swiss authorities cut a deal with its bigger rival UBS to acquire the troubled bank at a marked-down price. But European bank stocks and the wider market gained as investors watch whether moves to shore up banks will stem further upheaval in the global finan... Read the Full Story |
|
From Our PartnersFinally released to the public, trading guru Dave Aquino's guide, "The Options Trading Accelerator Method", reveals how Wall Street's big lie has stopped traders with small accounts from reaching their full potential and how his student favorite trading method could change that! | | Click here to keep reading… |
|
Markets | | In a bid to ease turmoil in the world financial system, Swiss authorities engineered a plan for the UBS bank to acquire its troubled smaller rival Credit Suisse at a marked-down price.It's another urgent attempt to fight fears that have put the financial world on edge 15 years after the failure of U... Read the Full Story |
|
Markets | |
Every investor knows that “let the buyer beware” is always sound advice. And when you throw in a global banking crisis, that should make investors very cautious. In the midst of this, it can be easy to overlook a small-cap stock like SoFi Technologies, Inc. (NASDAQ: SOFI). The company ... Read the Full Story |
|
From Our PartnersPorter Stansberry here -- I reveal the shocking changes this Obama policy will usher in… what it means for you, your family, and your finances… and how you can prepare for this new American era.
Stream my new documentary at no cost today. | Click here now - and watch it before it is removed |
|
Markets | |
Signs within the RH (NYSE: RH) report indicate that a bottom could be in play for the stock. While results are worse than the Marketbeat.com consensus figures and the guidance is poor, there is an expectation for margin improvement throughout the year. The company is doubling-down on restructuring... Read the Full Story |
|
Markets | |
Paychex, Inc. (NASDAQ: PAYX) isn’t a value stock but offers value and yield to investors. Trading at 27X its earnings, it is fairly valued compared to peer Automatic Data Processing (NYSE: ADP) and pays a significantly higher yield. The stock delivers a 2.75% yield, with shares trading near ... Read the Full Story |
|
From Our PartnersGet a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation. | | Analyze Any Stock Free |
|
Markets | | Working against the clock to stop a developing banking crisis, Treasury Secretary Janet Yellen had until sunset on Sunday, March 12, to come up with a plan to calm the U.S. economy. She quickly turned to someone who had been through the fire before, and on a much larger scale: Hank Paulson. Paulson,... Read the Full Story |
|
Markets | |
If you’ve been watching the short interest in EVGo (NYSE: EVGO) and wondering when and if a squeeze will happen, it is. The company’s q4 results and outlook affirm the business potential and have the stock up 25%. That is a significant move driven by short-covering that confirms suppor... Read the Full Story |
|
Markets | |
Dividend King H.B. Fuller (NYSE: FUL) is not an exciting stock but can be a telling indicator of economic activity. The company makes glue and adhesives for all end market uses, a leading input for all industries. The company’s results don’t point to dividend cuts or suspensions but su... Read the Full Story |
|
Markets | | While Wall Street works to contain the biggest American bank failure since the 2008 financial meltdown, founders of startups who are people of color worry it could become even harder to secure financial support Read the Full Story |
|
Stocks | | Two large banks that cater to the tech industry have collapsed after a bank run, government agencies are taking emergency measures to backstop the financial system, and President Joe Biden is reassuring Americans that the money they have in banks is safe Read the Full Story |
|
Friday's Early Bird Stock Of The Day 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis; and for the treatment of severe hypertriglyceridemia. The company was incorporated in 2018 and is headquartered in San Francisco, California. | View Today's Stock Pick |
|